Amgevita

Under Amgen and AbbVie agreement, rival drug to AbbVie's Humira expected to launch in 2023
Marketwatch
Thu, 09/28/17 - 09:50 am
Amgen
AbbVie
Humira
Amgevita
biosimilars
drug launches
$5B in Humira sales at stake with Amgen EU approval
BioPharma Dive
Sat, 03/25/17 - 12:18 pm
Humira
Amgen
Europe
rheumatoid arthritis
Amgevita
biosimiliars